How many undiagnosed and untreated COPD patients are there in Japan?

According to AstraZeneca's announcement, it is estimated that about 5 million out of the approximately 5.3 million estimated COPD patients in Japan are undiagnosed or untreated potential patients.

What are the main contents of the initiative by Koriyama City and AstraZeneca?

The main contents include individual notifications to high-risk COPD patients to encourage medical consultations, and the listing of cooperative medical institutions capable of initial diagnosis based on the 'COPD-F Protocol' to establish a system for early consultation and continuous treatment.

What is the COPD target in 'Healthy Japan 21 (Third Edition)?'

A new numerical target has been set to reduce the COPD mortality rate to 10.0 per 100,000 population by fiscal year 2032.

AI News NQ Analysis

AstraZeneca Promotes New COPD Countermeasures Aimed at Extending Healthy Life Expectancy in Koriyama City

NQ Score 80/100

N1 Content Completeness 9

AI Summary (NQ-processed)

AstraZeneca, in collaboration with Koriyama City, held a kickoff seminar to promote new COPD countermeasures aimed at extending healthy life expectancy through regional medical cooperation and early detection.

AI Analysis

Frequently Asked Questions

Q: How many undiagnosed and untreated COPD patients are there in Japan?: A: According to AstraZeneca's announcement, it is estimated that about 5 million out of the approximately 5.3 million estimated COPD patients in Japan are undiagnosed or untreated potential patients.
Q: What are the main contents of the initiative by Koriyama City and AstraZeneca?: A: The main contents include individual notifications to high-risk COPD patients to encourage medical consultations, and the listing of cooperative medical institutions capable of initial diagnosis based on the 'COPD-F Protocol' to establish a system for early consultation and continuous treatment.
Q: What is the COPD target in 'Healthy Japan 21 (Third Edition)?': A: A new numerical target has been set to reduce the COPD mortality rate to 10.0 per 100,000 population by fiscal year 2032.